推薦產品
等級
pharmaceutical primary standard
API 家族
octinoxate
製造商/商標名
USP
應用
pharmaceutical (small molecule)
格式
neat
SMILES 字串
CCCCC(CC)COC(=O)\C=C\c1ccc(OC)cc1
InChI
1S/C18H26O3/c1-4-6-7-15(5-2)14-21-18(19)13-10-16-8-11-17(20-3)12-9-16/h8-13,15H,4-7,14H2,1-3H3/b13-10+
InChI 密鑰
YBGZDTIWKVFICR-JLHYYAGUSA-N
尋找類似的產品? 前往 產品比較指南
一般說明
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
應用
Octinoxate USP reference standard suitable for use in specified USP compendial quality tests and assays.
Also used to prepare standard and system suitability solution during the assay of Octinoxate by using gas chromatography in conjunction with flame ionization detector.
Also used to prepare standard and system suitability solution during the assay of Octinoxate by using gas chromatography in conjunction with flame ionization detector.
分析報告
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
其他說明
Sales restrictions may apply.
危險聲明
防範說明
危險分類
Aquatic Chronic 4
儲存類別代碼
10 - Combustible liquids
水污染物質分類(WGK)
WGK 2
閃點(°F)
379.4 °F
閃點(°C)
193 °C
分析證明 (COA)
輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。
客戶也查看了
Octinoxate
United States Pharmacopeia, 43(3), 3225-3225 (2020)
Journal of the American College of Cardiology, 65(10), 999-1009 (2015-03-15)
Treatment for claudication that is due to aortoiliac peripheral artery disease (PAD) often relies on stent revascularization (ST). However, supervised exercise (SE) is known to provide comparable short-term (6-month) improvements in functional status and quality of life. Longer-term outcomes are
我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務